SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hoyt Casey

(Last)

(First)

(Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE

70508

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2020

3. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	2,073,185	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options	⁽¹⁾	01/04/2028	Common Shares	134,166	$2.27⁽²⁾	D
Stock Options	⁽³⁾	01/17/2029	Common Shares	305,802	$5.49⁽²⁾	D
Stock Options	⁽⁴⁾	01/17/2030	Common Shares	231,201	$7.44⁽²⁾	D
Restricted Share Units	⁽⁵⁾	01/04/2021	Common Shares	101,999	$0.0⁽⁶⁾	D

Explanation of Responses:

1. Options granted to reporting person on January 4, 2018, which vest in three equal installments beginning on the first anniversary of the grant date.

2. Denominated and reported in Canadian dollars.

3. Options granted to reporting person on January 17, 2019, which vest in three equal installments beginning on the first anniversary of the grant date.

4. Options granted to reporting person on January 17, 2020, which vest in three equal installments beginning on the first anniversary of the grant date.

5. Restricted Share Units granted to reporting person on January 4, 2018, which vest on January 4, 2021.

6. Each Restricted Share Unit represents the conditional right to receive one share of common stock and may be settled in common shares or a cash payment equal to the fair market value of common shares, or a combination thereof.

Remarks:

As the Company no longer qualifies as a foreign private issuer, effective January 1, 2021, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company has determined that it qualified as a foreign private issuer under the Exchange Act and has made use of the foreign private issuer accommodations under U.S. securities laws.

	/s/ Casey Hoyt	12/31/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.